ABOUT THIS EVENT
Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune disease, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Pete Salzmann, M.D, Chief Executive Officer, rang the Opening Bell.